A graphical representation verifying the binding strength between the antibodies designed by GaluxDesign and each therapeutic ...

Revolutionary Success in Predicting Future-Resistant Antibodies In a groundbreaking 2021-2022 project, Ainnocence's AI platform designed 50 antibodies capable of targeting approximately 1,300 ...

Next, the researchers will work to design bispecific antibodies that would be effective against all coronaviruses, the virus family including the ones that cause the common cold, MERS, and COVID-19.

a South Korean startup specializing in AI-driven protein therapeutics design, has published a study showcasing the capabilities of its AI platform, GaluxDesign, in de novo antibody design.

Next, the researchers will work to design bispecific antibodies that would be effective against all coronaviruses, the virus family including the ones that cause the common cold, MERS, and COVID-19.

Clonal bursting in germinal center as seen with Brainbow imaging (Courtesy of the Victora lab) Germinal centers are ...

An effective HIV-1 vaccine must therefore elicit antibodies that can neutralize many variants of the virus. While broadly neutralizing antibodies (bnAbs) have been isolated from HIV-1 infected ...